2006
DOI: 10.1080/j157v06n03_05
|View full text |Cite
|
Sign up to set email alerts
|

Wound-Healing Property ofMomordica charantiaL. Fruit Powder

Abstract: Momordica charantia Linn. fruit powder, in the form of an ointment (10% w/w dried powder in simple ointment base), was evaluated for wound-healing potential in an excision, incision and dead space wound model in rats. The rats were divided into three groups of control, treatment and reference in all three wound models, each group consisting of six rats. Wound-contraction ability in excision wound mode was measured at different time intervals on days 4, 8, 10, 12 and 14 , and the study was continued until the w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2023
2023

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…The wound-healing efficacy of M. charantia fruit powder was studied in rats utilizing an excision, incision, and dead space wound model. The powder ointment showed a statistically significant response in wound-contracting ability, wound closure time, length of epithelization, wound tensile strength, and wound tissue regeneration compared to the control group[ 119 ]. A study evaluated the alterations in transforming growth factor (TGF) expression in diabetic lesions treated with topical M. charantia fruit extract.…”
Section: Discussionmentioning
confidence: 99%
“…The wound-healing efficacy of M. charantia fruit powder was studied in rats utilizing an excision, incision, and dead space wound model. The powder ointment showed a statistically significant response in wound-contracting ability, wound closure time, length of epithelization, wound tensile strength, and wound tissue regeneration compared to the control group[ 119 ]. A study evaluated the alterations in transforming growth factor (TGF) expression in diabetic lesions treated with topical M. charantia fruit extract.…”
Section: Discussionmentioning
confidence: 99%
“…It is widely distributed in tropical regions of South East and Far East Asia to Australia and South Africa. M. charantia possesses antidiabetic, antihyperlipidemic and anticarcinogenic anti-HIV, anthelmintic, antitumor, and wound healing properties [15, 16, 17, 18, 19]. Fresh juice of bitter melon inhibited lipogenesis [20].…”
Section: Introductionmentioning
confidence: 99%